Skip navigation

Refine by Type

Results 1 - 8 of 8 for REGORAFENIB
  1. Regorafenib is used to treat colon and rectal cancer (cancer that begins in the large intestine or ... not been treated successfully with certain other medications. Regorafenib is in a class of medications called kinase ...
  2. ... Patients with Advanced GIST A new oral drug, regorafenib (Stivarga®), may delay the progression of advanced gastrointestinal ... in The Lancet demonstrated that patients treated with regorafenib lived longer without their disease progressing than patients ...
  3. Drugs Approved for Colon and Rectal Cancer From the National Institutes of Health (National Cancer Institute)  
    ... Fluorouracil) Fluorouracil Irinotecan Hydrochloride Leucovorin Calcium Oxaliplatin Panitumumab Regorafenib Stivarga (Regorafenib) Vectibix (Panitumumab) Wellcovorin (Leucovorin Calcium) Xeloda ( ...
  4. ... sunitinib is no longer working, the targeted drug regorafenib (Stivarga) may help some patients. Tumors that are ... be helpful. If sunitinib is no longer working, regorafenib may help some patients. If the tumor shrinks ...
  5. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... Erbitux®) , panitumumab (Vectibix®) , bevacizumab (Avastin®) , ziv-aflibercept (Zaltrap®) , regorafenib (Stivarga®) Dermatofibrosarcoma protuberans: Imatinib mesylate (Gleevec®) Head and ...
  6. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Recombinant HPV Quadrivalent Vaccine Recombinant Interferon Alfa-2b Regorafenib Revlimid (Lenalidomide) Rheumatrex (Methotrexate) Rituxan (Rituximab) Rituximab Romidepsin ...
  7. ... size. Sorafenib (Nexavar ® ), bevacizumab (Avastin ® ), pazopanib (Votrient ® ), and regorafenib (Stivarga ® ) are examples of drugs that target blood ...
  8. ... U.S. Food and Drug Administration today approved Stivarga (regorafenib) to treat patients with colorectal cancer that has ...